These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 24270950)

  • 21. Regular insulin added to total parenteral nutrition vs subcutaneous glargine in non-critically ill diabetic inpatients, a multicenter randomized clinical trial: INSUPAR trial.
    Olveira G; Abuín J; López R; Herranz S; García-Almeida JM; García-Malpartida K; Ferrer M; Cancer E; Luengo-Pérez LM; Álvarez J; Aragón C; Ocón MJ; García-Manzanares Á; Bretón I; Serrano-Aguayo P; Pérez-Ferre N; López-Gómez JJ; Olivares J; Arraiza C; Tejera C; Martín JD; García S; Abad ÁL; Alhambra MR; Zugasti A; Parra J; Torrejón S; Tapia MJ
    Clin Nutr; 2020 Feb; 39(2):388-394. PubMed ID: 30930133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of Initiation of Basal Insulin Analogs vs Neutral Protamine Hagedorn Insulin With Hypoglycemia-Related Emergency Department Visits or Hospital Admissions and With Glycemic Control in Patients With Type 2 Diabetes.
    Lipska KJ; Parker MM; Moffet HH; Huang ES; Karter AJ
    JAMA; 2018 Jul; 320(1):53-62. PubMed ID: 29936529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycemic control and sliding scale insulin use in medical inpatients with diabetes mellitus.
    Queale WS; Seidler AJ; Brancati FL
    Arch Intern Med; 1997 Mar; 157(5):545-52. PubMed ID: 9066459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. (Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus.
    Semlitsch T; Engler J; Siebenhofer A; Jeitler K; Berghold A; Horvath K
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD005613. PubMed ID: 33166419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.
    Rossetti P; Pampanelli S; Fanelli C; Porcellati F; Costa E; Torlone E; Scionti L; Bolli GB
    Diabetes Care; 2003 May; 26(5):1490-6. PubMed ID: 12716810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dosing of insulin glargine in the treatment of type 2 diabetes.
    Barnett A
    Clin Ther; 2007 Jun; 29(6):987-99. PubMed ID: 17692716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of prandial versus fasting glycemia on cardiovascular outcomes in type 2 diabetes: the HEART2D trial.
    Raz I; Wilson PW; Strojek K; Kowalska I; Bozikov V; Gitt AK; Jermendy G; Campaigne BN; Kerr L; Milicevic Z; Jacober SJ
    Diabetes Care; 2009 Mar; 32(3):381-6. PubMed ID: 19246588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A pilot study to evaluate the effectiveness of glargine and multiple injections of lispro in patients with type 2 diabetes receiving tube feedings in a cardiovascular intensive care unit.
    Grainger A; Eiden K; Kemper J; Reeds D
    Nutr Clin Pract; 2007 Oct; 22(5):545-52. PubMed ID: 17906278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retrospective Evaluation of Glycemic Control With Basal-Bolus or Neutral Protamine Hagedorn Insulin Regimens in Patients Receiving Continuous Enteral Nutrition Therapy in Medicine Wards.
    Hijaze D; Szalat A
    Nutr Clin Pract; 2017 Aug; 32(4):557-562. PubMed ID: 28760108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucose control in acute myocardial infarction: a pilot randomized study controlled by continuous glucose monitoring system comparing the use of insulin glargine with standard of care.
    Sampaio CR; Franco DR; Goldberg DJ; Baptista J; Eliaschewitz FG
    Diabetes Technol Ther; 2012 Feb; 14(2):117-24. PubMed ID: 22181063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metformin as an adjunct to insulin for glycemic control in patients with type 2 diabetes after CABG surgery: a randomized double blind clinical trial.
    Baradari AG; Emami Zeydi A; Aarabi M; Ghafari R
    Pak J Biol Sci; 2011 Dec; 14(23):1047-54. PubMed ID: 22590838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intensive insulin therapy for patients in paediatric intensive care: a prospective, randomised controlled study.
    Vlasselaers D; Milants I; Desmet L; Wouters PJ; Vanhorebeek I; van den Heuvel I; Mesotten D; Casaer MP; Meyfroidt G; Ingels C; Muller J; Van Cromphaut S; Schetz M; Van den Berghe G
    Lancet; 2009 Feb; 373(9663):547-56. PubMed ID: 19176240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Premeal insulin lispro plus bedtime NPH or twice-daily NPH in patients with type 2 diabetes: acute postprandial and chronic effects on glycemic control and cardiovascular risk factors.
    Ceriello A; Del Prato S; Bue-Valleskey J; Beattie S; Gates J; de la Peña A; Malone J
    J Diabetes Complications; 2007; 21(1):20-7. PubMed ID: 17189870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of an insulin bolus advisor improves glycemic control in multiple daily insulin injection (MDI) therapy patients with suboptimal glycemic control: first results from the ABACUS trial.
    Ziegler R; Cavan DA; Cranston I; Barnard K; Ryder J; Vogel C; Parkin CG; Koehler W; Vesper I; Petersen B; Schweitzer MA; Wagner RS
    Diabetes Care; 2013 Nov; 36(11):3613-9. PubMed ID: 23900590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation of the DeLiT Trial intravenous insulin infusion algorithm for intraoperative glucose control in noncardiac surgery: a randomized controlled trial.
    Abdelmalak B; Maheshwari A; Kovaci B; Mascha EJ; Cywinski JB; Kurz A; Kashyap VS; Sessler DI
    Can J Anaesth; 2011 Jul; 58(7):606-616. PubMed ID: 21598057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of bedtime snack composition on prevention of nocturnal hypoglycemia in adults with type 1 diabetes undergoing intensive insulin management using lispro insulin before meals: a randomized, placebo-controlled, crossover trial.
    Kalergis M; Schiffrin A; Gougeon R; Jones PJ; Yale JF
    Diabetes Care; 2003 Jan; 26(1):9-15. PubMed ID: 12502652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin Pump and Continuous Glucose Monitor Initiation in Hospitalized Patients with Type 2 Diabetes Mellitus.
    Levitt DL; Spanakis EK; Ryan KA; Silver KD
    Diabetes Technol Ther; 2018 Jan; 20(1):32-38. PubMed ID: 29293367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A MULTICENTER STUDY EVALUATING PERCEPTIONS AND KNOWLEDGE OF INPATIENT GLYCEMIC CONTROL AMONG RESIDENT PHYSICIANS: ANALYZING THEMES TO INFORM AND IMPROVE CARE.
    Horton WB; Law S; Darji M; Conaway MR; Akbashev MY; Kubiak NT; Kirby JL; Thigpen SC
    Endocr Pract; 2019 Dec; 25(12):1295-1303. PubMed ID: 31412227
    [No Abstract]   [Full Text] [Related]  

  • 39. Construction and preliminary evaluation of the inpatient glycemic control questionnaire (IGCQ): a survey tool assessing perceptions and knowledge of resident physicians.
    Horton WB; Law S; Darji M; Conaway MR; Kubiak NT; Kirby JL; Thigpen SC
    BMC Med Educ; 2019 Jun; 19(1):228. PubMed ID: 31234836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of a multi-component quality improvement intervention on rates of hyperglycaemia.
    Franco T; Aaronson B; Brown L; Blackmore C; Rupp S; Lee G
    BMJ Open Qual; 2017; 6(2):e000059. PubMed ID: 29450273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.